NRx Pharma Secures $5M Advance in Milestone Payment for Bipolar Depression Drug
RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a biopharmaceutical company based in Pennsylvania, has announced the receipt of an advanced milestone payment of $5 million from its partners, Alvogen, …
NRx Pharma Secures $5M Advance in Milestone Payment for Bipolar Depression Drug Read More